Not a word about competitions !! I'm using videotron, and a new service a la nflx is starting this saterday.... a lot of +1,5 years old movies + many series + many more.....
My observations, Good news VVUS =down day for ARNA, Bad news for VVUS= down day for ARNA, bad news for ARNA = down day for ARNA, good news for ARNA= flat day to down day for ARNA. Skipping all the BS from that hypsters, and bashers, would like to see ARNA trade on its own
No, I know that is what should happen. But who sets the price anyway. Its supply and demand. And premarket orders influence the trading cycle prices. Its not like market makers are ordered to price adjust according to the split. If unknowing noobs still think it was trading normal, they'd price the thing back up even though legitimately it should have been price adjusted down after the ex-dividend last friday.
Or, this is a major scam operation for a period of a week.
Finally, an LTE Chip That Will Work Anywhere in the World
Qualcomm has announced something that will make travellers everywhere very happy: a new radio chipset that can support every LTE network in the world.
More accurately, the RF360 chips provides connectiviry for LTE-FDD, LTE-TDD, WCDMA, EV-DO, CDMA 1x, TD-SCDMA and GSM/EDGE networks. That should be enough, though, as it currently covers every LTE network in use across the globe.
That'll be of interest to manufacturers and consumers alike. Not only will it make travelling easier, it will allow companies to make a single phone to ship around the world, instead of having to make different phones for different markets
IM NOT BUYING BUT I COVERED MY SHORT YESTERDAY
NO COMPANY SPLITS BEFORE EARNINGS WITH BAD NUMBERS
ANOTHERENIGMA BOUGHT YESTERDAY AT 56
HE DOESN'T BUY BLINDLY
HE'S A LOSER BUT NOT A DUMB TRADER
DDD GOES UP TODAY AND NEXT WEEK BIG TIME
I LOVE CTIC: I bought that stock back around April 2011 at around 2.00, first part of June it was over 10.00, MADE A TON ON IT... You just have to Know when to hold them, Know when to fold'em... never heard the song, you need to learn to trade stock, NOT BASH THEM AFTER THE FACT you screwed up.
could also be used by sony/vmw to make playstation 4 available via hand controller? with the majority of computing done on web. a 'client /server' thing with telephony.......gosh, vcsy describes maybe the new sony controller...thin client controlling ibm blade server...with shadowing capabilities and outright take control of it. ibm /clearcube/with ibm rack blades as the server? citrix/msft/oracle/netscape/ibm/hp-neoware/vcsy=ihope;
The question is: do we also zoom, zoom out of the market any where we can grab acorns ?
I think the rally is going to stall .... I will exit all winning positions and hold the balance today.
Remember.... Hfc reports next week and the CC will be a huge winner. Great Q4 and wonderful Q1 estimates.
UCB - ConfometRx Collaborate
By Zacks Equity Research | Zacks – 14 hours ago.. .
UCB (UCBJY) recently entered into an agreement with ConfometRx for the discovery of novel medicines in the neuroscience therapeutic area. This research and development (R&D) collaboration, spanning two years, will harness structural biology to gain insight into G protein coupled receptors (GPCRs) modulation in making drugs.
ConfometRx is developing a platform of structure-based drug discovery technologies to facilitate lead identification and lead optimization for GPCR.
UCB also has R&D alliances with Harvard. UCB and Harvard have three collaborative R&D projects since 2011. In Oct 2012, the third project was signed to study the microbiome in the human intestine, classifying new species and studying their impact on the immune system in order to identify new drugs for preventing or treating immunological diseases. For this study, UCB will provide Harvard up to $4.5 million.
The major neuroscience products at UCB include Vimpat (lacosamide) and Neupro (rotigotine). Vimpat and Neupro revenues for the nine months ending Sep 30, 2012 were € 237 million and € 93 million respectively.
In Dec 2012, UCB received Japanese approval for Neupro for Parkinson’s disease and restless legs syndrome. The drug was approved in the EU and US in 2006 and 2007, respectively.
Vimpat was first launched in the EU in Sep 2008, as an adjunctive therapy for treating adults and adolescents (16-18 years) suffering from partial-onset seizures (with or without secondary generalization) with epilepsy.
Earlier this month, Vimpat was approved in the EU as a single loading dose option for treating patients suffering from partial onset seizures.
UCB carries a Zacks Rank #3 (Hold). Currently, companies like Lannett Company, Inc. (LCI), SIGA Technologies, Inc. (SIGA) and United Therapeutics Corporation (UTHR) look more attractive with a Zacks Rank #1 (Strong Buy).
Looks like the bear trap has been set.
Jamies website is UP and available...the YAHOO POLICE are forbidding me from posting it so I ask that you guys google his name...[Jamie McKinley blog] and read it for yourselves and again on behalf of his Team Zap-IT at Duke and his Oncologist Dr Friedman, I ask that you give generously on behalf of Jamie and Meme who we here at Yahoo CLDX hold dear to our Hearts and Minds!
5 Years Jamie..YOU ARE BLESSED!